- Home
- HOFT vs XFOR Comparison
HOFT vs XFOR Comparison
Compare HOFT & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOFT
- XFOR
- Stock Information
- Founded
- HOFT 1924
- XFOR 2014
- Country
- HOFT United States
- XFOR United States
- Employees
- HOFT N/A
- XFOR N/A
- Industry
- HOFT Home Furnishings
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOFT Consumer Discretionary
- XFOR Health Care
- Exchange
- HOFT Nasdaq
- XFOR Nasdaq
- Market Cap
- HOFT 104.6M
- XFOR 118.4M
- IPO Year
- HOFT 1999
- XFOR N/A
- Fundamental
- Price
- HOFT $9.82
- XFOR $3.40
- Analyst Decision
- HOFT
- XFOR Strong Buy
- Analyst Count
- HOFT 0
- XFOR 3
- Target Price
- HOFT N/A
- XFOR $72.33
- AVG Volume (30 Days)
- HOFT 48.7K
- XFOR 180.2K
- Earning Date
- HOFT 06-12-2025
- XFOR 05-01-2025
- Dividend Yield
- HOFT 9.37%
- XFOR N/A
- EPS Growth
- HOFT N/A
- XFOR N/A
- EPS
- HOFT N/A
- XFOR 2.16
- Revenue
- HOFT $397,465,000.00
- XFOR $31,364,000.00
- Revenue This Year
- HOFT $3.58
- XFOR $915.88
- Revenue Next Year
- HOFT $7.66
- XFOR N/A
- P/E Ratio
- HOFT N/A
- XFOR $1.57
- Revenue Growth
- HOFT N/A
- XFOR N/A
- 52 Week Low
- HOFT $7.34
- XFOR $2.67
- 52 Week High
- HOFT $19.79
- XFOR $33.90
- Technical
- Relative Strength Index (RSI)
- HOFT 55.02
- XFOR 39.83
- Support Level
- HOFT $8.98
- XFOR $2.67
- Resistance Level
- HOFT $9.74
- XFOR $3.56
- Average True Range (ATR)
- HOFT 0.43
- XFOR 0.28
- MACD
- HOFT 0.04
- XFOR 0.21
- Stochastic Oscillator
- HOFT 54.66
- XFOR 82.02
About HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.